9FQ-16219-87114
4 vaccinations
4 coded responses
27 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 358 / AL
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-22
Dose 1 — Moderna
- 2021-01-22
- 2021-01-23
- 2021-01-24
-
2021-01-25
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue, Headache — Feeling: Good · Site: ItchingFree text: Note: on Saturday after I turned in my response I realized I did have both fatigue and a head ache. They were gone Sun morning but I was unable to update the previous information.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
- 2021-01-29
-
2021-02-05
Survey response — day 14, dose 1MedDRA: Injection site pruritus, Injection site rash, Injection site swelling — Feeling: GoodFree text: Covid arm: slight rash started Friday (1-29), on Sat it was a larger swollen area. Both itched, but was tolerable. It was gone by Monday evening.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
-
2021-02-19
Dose 2 — Moderna
- 2021-02-26
- 2021-03-05
- 2021-03-13
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-21
-
2021-08-20
Survey response — 6 months, dose 2MedDRA: Hypersensitivity, Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Body rash, likely allergic reaction to a supplement. Went away after 5 days of steroids. · Healthcare visit (other): Later visited an allergist and will have testing soon.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-20
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-26
-
2021-08-26
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-09-12
Dose 3 — Moderna
- 2022-02-19
- 2022-03-13
-
2022-04-02
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-16
- 2022-04-23
- 2022-04-30
- 2022-05-07
- 2022-05-14
- 2022-10-01
-
2023-04-04
Survey response — 12 months, dose 4MedDRA: Influenza, Nasopharyngitis, Sinusitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-04
Report sent to call center — 12 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-04-05
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Moderna | |
| 2 | 2021-02-19 | Moderna | |
| 3 | 2021-09-12 | Moderna | No |
| 4 | 2022-04-02 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Note: on Saturday after I turned in my response I realized I did have both fatigue and a head ache. They were gone Sun morning but I was unable to update the previous information.
Release 3 — day 14, dose 1
Symptoms: Covid arm: slight rash started Friday (1-29), on Sat it was a larger swollen area. Both itched, but was tolerable. It was gone by Monday evening.
Release 9 — 6 months, dose 2
Symptoms: Body rash, likely allergic reaction to a supplement. Went away after 5 days of steroids.
Healthcare visit (other): Later visited an allergist and will have testing soon.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Hypersensitivity | ✓ | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rash | ✓ | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release